Publication:
Mesalazine-induced bullous fixed drug eruption

Simple item page
dc.contributor.authorSALMAN, ANDAÇ
dc.contributor.authorSEÇKİN GENÇOSMANOĞLU, DİLEK
dc.contributor.authorÖZEN ALAHDAB, YEŞİM
dc.contributor.authorsSalman, Andac; Gencosmanoglu, Dilek Seckin; Alahdab, Yesim O.; Gimenez-Arnau, Ana M.
dc.date.accessioned2022-03-09T14:45:56Z
dc.date.accessioned2026-01-11T16:50:51Z
dc.date.available2022-03-09T14:45:56Z
dc.identifier.doi10.1111/cod.12972
dc.identifier.eissn1600-0536
dc.identifier.issn0105-1873
dc.identifier.pubmed29446099
dc.identifier.urihttps://hdl.handle.net/11424/219188
dc.identifier.wosWOS:000434217900006
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofCONTACT DERMATITIS
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subject5-aminosalicylic acid
dc.subjectcase report
dc.subjectfixed drug eruption
dc.subjectmesalazine
dc.subjectSULFASALAZINE
dc.subjectMANAGEMENT
dc.subjectDISEASE
dc.titleMesalazine-induced bullous fixed drug eruption
dc.typeeditorial
dspace.entity.typePublication
oaire.citation.endPage35
oaire.citation.issue1
oaire.citation.startPage34
oaire.citation.titleCONTACT DERMATITIS
oaire.citation.volume79

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
93.47 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları